CIVERA, MONICA
 Distribuzione geografica
Continente #
EU - Europa 4.921
NA - Nord America 4.425
AS - Asia 4.037
SA - Sud America 407
AF - Africa 108
OC - Oceania 34
Continente sconosciuto - Info sul continente non disponibili 1
Totale 13.933
Nazione #
US - Stati Uniti d'America 4.301
CN - Cina 1.329
GB - Regno Unito 1.242
SG - Singapore 1.144
IT - Italia 1.027
DE - Germania 768
SE - Svezia 444
HK - Hong Kong 412
RU - Federazione Russa 368
IN - India 320
BR - Brasile 298
NL - Olanda 213
FR - Francia 185
TR - Turchia 176
IE - Irlanda 137
KR - Corea 131
JP - Giappone 112
UA - Ucraina 112
FI - Finlandia 104
VN - Vietnam 97
ID - Indonesia 92
CA - Canada 82
DK - Danimarca 59
CI - Costa d'Avorio 51
EU - Europa 46
ES - Italia 40
CO - Colombia 37
BE - Belgio 35
IR - Iran 35
AU - Australia 32
BD - Bangladesh 31
AR - Argentina 27
LV - Lettonia 27
CH - Svizzera 26
MX - Messico 26
GR - Grecia 25
PK - Pakistan 25
PH - Filippine 23
PL - Polonia 23
AT - Austria 17
CZ - Repubblica Ceca 17
RO - Romania 17
TW - Taiwan 15
IQ - Iraq 14
MY - Malesia 14
EC - Ecuador 12
EG - Egitto 11
ZA - Sudafrica 11
UZ - Uzbekistan 10
CL - Cile 9
SA - Arabia Saudita 9
TH - Thailandia 9
JO - Giordania 8
KE - Kenya 8
VE - Venezuela 8
HR - Croazia 7
MA - Marocco 7
BO - Bolivia 6
IL - Israele 5
JM - Giamaica 5
NP - Nepal 5
PY - Paraguay 5
SC - Seychelles 5
TT - Trinidad e Tobago 5
AE - Emirati Arabi Uniti 4
LT - Lituania 4
NO - Norvegia 4
PE - Perù 4
PT - Portogallo 4
CY - Cipro 3
DO - Repubblica Dominicana 3
DZ - Algeria 3
ET - Etiopia 3
KZ - Kazakistan 3
SI - Slovenia 3
AO - Angola 2
AZ - Azerbaigian 2
BY - Bielorussia 2
EE - Estonia 2
GH - Ghana 2
HU - Ungheria 2
NG - Nigeria 2
NZ - Nuova Zelanda 2
OM - Oman 2
SK - Slovacchia (Repubblica Slovacca) 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BN - Brunei Darussalam 1
CG - Congo 1
CR - Costa Rica 1
GT - Guatemala 1
IM - Isola di Man 1
KG - Kirghizistan 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LU - Lussemburgo 1
PA - Panama 1
Totale 13.974
Città #
Southend 1.043
Singapore 616
Milan 449
Ashburn 448
Chandler 408
Hong Kong 346
Seattle 248
Beijing 243
Hanover 242
Dallas 195
Fairfield 190
Princeton 174
Wilmington 171
Ann Arbor 135
Dublin 134
Council Bluffs 131
Los Angeles 124
Hefei 121
Woodbridge 108
Dearborn 104
Mountain View 102
Bengaluru 85
Houston 81
Nanjing 76
Phoenix 75
San Jose 73
Cambridge 70
Santa Clara 67
Redmond 66
Redwood City 63
Munich 62
Frankfurt am Main 60
Jakarta 59
Jacksonville 57
Tokyo 55
Toronto 54
Abidjan 51
Des Moines 51
Shanghai 51
Buffalo 48
Istanbul 46
Guangzhou 44
Boardman 43
Shenyang 39
Medford 36
Somerville 36
Moscow 35
Andover 34
Ho Chi Minh City 34
Hangzhou 33
Jinan 33
Sakarya 33
Eitensheim 32
Bogotá 31
Mumbai 31
Grafing 30
São Paulo 30
New York 29
Tianjin 29
Cangzhou 27
Brussels 26
Bologna 25
Helsinki 25
Hanoi 24
Seoul 24
Serra 24
Columbus 23
Nanchang 22
Berlin 20
Chicago 20
Hyderabad 20
Changsha 19
The Dalles 18
Turku 18
Nuremberg 17
Pavia 17
Bitonto 16
Hamburg 16
Kent 16
Kwun Tong 16
Central 15
Warsaw 15
Dhaka 14
London 14
Pune 14
Izmir 13
Odernheim 13
Portage 13
San Diego 13
Stockholm 13
Turin 13
Athens 12
Barcelona 12
Boston 12
Fuzhou 12
Hebei 12
Kiez 12
Napoli 12
Ningbo 12
Brooklyn 11
Totale 8.284
Nome #
Nature-inspired and medicinally relevant short peptides 484
Side chain effect in the modulation of αvβ3/α5β1 integrin activity via clickable isoxazoline-RGDmimetics: development of molecular delivery systems 438
New beta-lactam derivatives modulate cell adhesion and signaling mediated by RGD-binding and leukocyte integrins 363
Crystal structure of human E-cadherin-EC1EC2 in complex with a peptidomimetic competitive inhibitor of cadherin homophilic interaction 350
Exploring E-cadherin-peptidomimetics interaction using NMR and computational studies 289
Molecular Dynamics Simulation of Aqueous Solutions of Trimethylamine-N-oxide and tert-Butyl Alcohol 280
Insights into the Binding of Cyclic RGD Peptidomimetics to a5b1 Integrin by using Live-Cell NMR And Computational Studies 277
On-Chip Screening of a Glycomimetic Library with C-Type Lectins Reveals Structural Features Responsible for Preferential Binding of Dectin-2 over DC-SIGN/R and Langerin 273
Computational design of novel peptidomimetic inhibitors of cadherin homophilic interactions 264
DENPOL: a program to determine ab initio quality electron densities for polypeptides 261
Behavior of glycolylated sialoglycans in the binding pockets of murine and human CD22 245
Unusual properties of aqueous solutions of L-Proline : a Molecular Dynamics study 234
Design and synthesis of peptidomimetic molecules targeting cadherin-mediated protein-protein interactions 227
Relaxing and Transferring Extremely Localized Molecular Orbitals 223
Thermodynamically-Weighted Conformational Ensemble of Cyclic RGD Peptidomimetics from NOE Data 216
GM1 oligosaccharide efficacy against α-synuclein aggregation and toxicity in vitro 212
Homology model of a catalytically competent bifunctional Rel protein 205
Structure-Based Design of RSH inhibitors to Hamper persistence 203
Cyclic isoDGR peptidomimetics as low-nanomolar αvβ 3 integrin ligands 202
Extremely localized molecular orbitals : theory and applications 201
Investigating the Interaction of Cyclic RGD Peptidomimetics with αVβ6 Integrin by Biochemical and Molecular Docking Studies 200
Potent integrin ligands containing a bifunctional diketopiperazine scaffold 193
Dimeric Smac mimetics/IAP inhibitors as in vivo-active pro-apoptotic agents. Part II : Structural and biological characterization 192
Cyclic isoDGR peptidomimetics as low-nanomolar αvβ3 integrin ligands 189
New Chemotypes for the Inhibition of (p)ppGpp Synthesis in the Quest for New Antimicrobial Compounds 185
Molecular dynamics simulation of aqueous solutions of glycine betaine 181
Synthesis of cyclic RGD peptidomimetics, containing a bifunctional diketopiperazine scaffold, as new integrin ligands 181
Interpretazione microscopica dell’effetto osmoprotettivo della taurina mediante dinamica 178
Modelling cadherin-mediated protein-protein interactions by atomistic simulations 177
RGD-based peptides targheting αIIbβ3 and αvβ3 integrin receptors: an NMR point of view 175
Synthesis of Gd and [68Ga] complexes in conjugation with a conformationally-optimized RGD sequence as potential MRI and PET tumour-imaging probes 172
Cyclic RGD-containing functionalized azabicycloalkane peptides as potent integrin antagonists for tumor targeting 171
New potent alpha(v)beta(3) integrin ligands based on azabicycloalkane (gamma,alpha)-dipeptide mimics 168
Design and synthesis of potent integrin ligands containing a bifunctional diketopiperazine scaffold 166
Synthesis and Conformational Studies of Peptidomimetics Containing a New Bifunctional Diketopiperazine Scaffold Acting as a beta-Hairpin Inducer 164
Molecular dynamics simulation of aqueous solutions of osmolytes 162
Chemical and Biophysical Approaches to Allosteric Modulation 162
PhthalaPhos : Chiral Supramolecular Ligands for Enantioselective Rhodium-Catalyzed Hydrogenation Reactions 161
A fragment-based virtual screening approach to identify e-cadherin lingands 161
STD and trNOESY NMR Study of Receptor-Ligand Interactions in Living Cancer Cells 159
Targeting protein-protein interactions in cancer with peptidomimetics: insights into ligand conformation and ligand-receptor interactions 159
Insights into molecular bases of cadherin : small ligands interaction by STD : NMR 159
A Comprehensive NMR Analysis of the Interaction between DKP-RGD Ligands and Membrane Proteins on Intact Cells 157
The Importance of Detail: How Differences in Ligand Structures Determine Distinct Functional Responses in Integrin α v β 3 155
Glycomimetic antagonists of BC2L-C lectin: insights from Molecular Dynamics simulations 152
High Affinity vs. Native Fibronectin in the Modulation of αvβ3 Integrin Conformational Dynamics : Insights from Computational Analyses and Implications for Molecular Design 152
Cyclic RGD and isoDGR Integrin Ligands Containing cis-2-amino-1-cyclopentanecarboxylic (cis-beta-ACPC) Scaffolds 151
Targeting integrins alphaVbeta3 and alphaIIbeta3 with RGD peptidomimetics : study of the ligand conformation and of the ligand-receptor interactions 150
Different behavior of cyclic RGD peptidomimetics versus a5b1 and aVb3 integrin-rich cancer cells: NMR and computational analysis 149
Antiangiogenic Effect of Dual/Selective alpha5beta1/alphavbeta3 Integrin Antagonists Designed on Partially Modified Retro-Inverso Cyclotetrapeptide Mimetics. 148
Determination of the binding epitope of RGD-peptidomimetics to αvβ3 and αIIbβ3 integrin-rich intact cells by NMR and computational studies 148
Peptidomimetic inhibitors of cadherin homophilic interactions: from computational design to ligand binding epitope by STD NMR 142
Tracking the interaction between α-Synuclein mutants and Tubulin Using DOSY (Diffusion Ordered Spectroscopy) NMR 141
PhthalaPhos : chiral supramolecular ligands for enantioselective hydrogenation reactions 140
Bromine-promoted glycosidation of conformationally superarmed thioglycosides 140
Binding of RGD-peptide mimics to intact human platelets : an NMR study 138
Cyclic RGD-Peptidomimetics Containing Bifunctional Diketopiperazine Scaffolds as New Potent Integrin Ligands 137
A library approach to the development of chiral supramolecular ligands for asymmetric hydrogenation 137
STD-NMR experiments on tumor cells to investigate RGD ligand - membrane protein interactions 136
Cyclic RGD peptidomimetics: insights into the binding to integrin-rich cancer cells by NMR and computational studies 134
Conformationally Constrained Sialyl Analogues as New Potential Binders of h-CD22 133
An integrated computational and NMR study of the first peptidimimetic inhibitors of cadherin homophilic interaction 130
A combined fragment-based virtual screening and STD-NMR approach for the identification of E-cadherin ligands 128
Synthesis and conformational analysis of β-hairpin mimics containing bifunctional diketopiperazine scaffolds 127
Structure based design of RSH inhibitors 127
Computer-aided design of peptidomimetic molecules targeting cadherin-mediated protein-protein interactions 125
Rhodium-catalyzed asymmetric hydrogenation of olefins with phthalaphos, a new class of chiral supramolecular ligands 122
Development of Isoxazoline-Containing Peptidomimetics as Dual alphaVbeta3 and alpha5beta1 Integrin Ligands 118
A library approach to the development of BenzaPhos: Highly efficient chiral supramolecular ligands for asymmetric hydrogenation 118
Achieving high affinity for a bacterial lectin with reversible covalent ligands 116
Foldamers of bifunctional diketopiperazines displaying a beta-bend ribbon structure 116
Tumor Carbohydrate Associated Antigen Analogs as Potential Binders for Siglec-7 113
Synthesis and conformational analysis of β-Harpin mimics containing bifunctional diketopiperazine scaffolds 111
Bifunctional 2,5-Diketopiperazines as Efficient Organocatalysts for the Enantioselective Conjugate Addition of Aldehydes to Nitroolefins 109
Reconstructing the free energy landscape of E-Cadherin conformational transition by metadynamics simulations 106
Investigating the interaction of peptidomimetic ligands with e-cadherin using NMR and computational studies 95
New Insights into the molecular mechanism of E-cadherin-mediated cell adhesion by free energy calculations 84
Crystal structure of human E-cadherin-EC1EC2 in complex with a peptidomimetic competitive inhibitor of cadherin homophilic interactions 78
Rhodium-Catalyzed Asymmetric Hydrogenation of Olefins with PhthalaPhos, a New Class of Chiral Supramolecular Ligands 77
Modulation of αvβ3- and α5β1-integrin-mediated adhesion by dehydro-β-amino acids containing peptidomimetics 72
Structure-based design of RelSeq inhibitors: growth of an amino benzoic acid fragment 71
Design of Cyclopeptidic Drugs 68
Evolution of SARS-CoV-2 spike trimers towards optimized heparan sulfate cross-linking and inter-chain mobility 61
Differential modulation of alphavbeta3 dynamics upon RGD-ligands 61
Targeting the RelSeq Synthetase Domain with Amino Benzoic Acid Centred Inhibitors 60
Synthesis and docking studies of glycolipids Inspired by Bacteroides fragilis lipid A 57
Interaction Between Heparan Sulfate Oligosaccharide and the Receptor-Binding Domain of the Wild-Type and Omicron Variant of the SARS-CoV-2 Spike Protein 37
Antifibrotic efficacy of a nintedanib−peptide conjugate and diagnostic potential of a fluorescent companion probe targeting αVβ6 integrin in idiopathic pulmonary fibrosis 34
Totale 14.523
Categoria #
all - tutte 39.847
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 39.847


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021623 0 0 0 0 0 0 93 83 102 124 154 67
2021/20221.252 74 66 51 59 106 135 130 90 133 90 108 210
2022/20231.359 170 138 138 147 140 233 26 92 143 29 60 43
2023/20241.032 30 87 71 65 190 81 65 79 43 100 94 127
2024/20252.544 111 231 62 227 150 134 117 263 158 297 238 556
2025/20262.866 442 475 510 513 460 299 167 0 0 0 0 0
Totale 14.523